Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A New Venue of TNF Targeting
Sophie Steeland, Claude Libert, Roosmarijn E. Vandenbroucke
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 5, pp. 1442-1442
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics
Dan-in Jang, A-Hyeon Lee, Hye-Yoon Shin, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2719-2719
Open Access | Times Cited: 1005
Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity
Andrea Padoan, Mario Plebani, Daniela Basso
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 3, pp. 676-676
Open Access | Times Cited: 284
Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage
Huimin Zhu, Zhiqiang Wang, Jixu Yu, et al.
Progress in Neurobiology (2019) Vol. 178, pp. 101610-101610
Closed Access | Times Cited: 263
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Yu‐Chyi Hwang, Ruei‐Min Lu, Shih-Chieh Su, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 201
Targeting co-stimulatory molecules in autoimmune disease
Natalie M. Edner, Gianluca Carlesso, James S. Rush, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 12, pp. 860-883
Closed Access | Times Cited: 165
Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice
Stefano Bruscoli, Marta Febo, Carlo Riccardi, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 132
Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection, Aging, and Neuroinflammation for the Modern Age
Ashley Payne, Samuel N. Nahashon, Equar Taka, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 371-371
Open Access | Times Cited: 108
The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections
Ren‐Jun Hsu, Wei-Chieh Yu, Guan-Ru Peng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 104
The roles of critical pro‐inflammatory cytokines in the drive of cytokine storm during SARS‐CoV‐2 infection
Muhammad Suhaib Qudus, Mingfu Tian, Summan Sirajuddin, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Open Access | Times Cited: 49
TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond
Daniela Siegmund, Harald Wajant
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 9, pp. 576-591
Closed Access | Times Cited: 43
Cartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review
Daisuke Tateiwa, Hideki Yoshikawa, Takashi Kaito
Cells (2019) Vol. 8, Iss. 8, pp. 818-818
Open Access | Times Cited: 131
COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue
Yongzhi Xi
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 266-276
Open Access | Times Cited: 83
Temporal profiling of cytokines in passively expressed sweat for detection of infection using wearable device
Badrinath Jagannath, Kai‐Chun Lin, Madhavi Pali, et al.
Bioengineering & Translational Medicine (2021) Vol. 6, Iss. 3
Open Access | Times Cited: 61
miRNAs as Biomarkers and Possible Therapeutic Strategies in Rheumatoid Arthritis
Tomasz Kmiołek, Agnieszka Paradowska‐Gorycka
Cells (2022) Vol. 11, Iss. 3, pp. 452-452
Open Access | Times Cited: 42
Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now
Mona A. Mohammed
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 23
Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues
Laurent Peyrin‐Biroulet, William J. Sandborn, Remo Panaccione, et al.
Therapeutic Advances in Gastroenterology (2021) Vol. 14
Open Access | Times Cited: 41
Identification of a binding site on soluble RANKL that can be targeted to inhibit soluble RANK-RANKL interactions and treat osteoporosis
Dane Huang, Chao Zhao, Ruyue Li, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 31
The core of maintaining neuropathic pain: Crosstalk between glial cells and neurons (neural cell crosstalk at spinal cord)
Tianrui Zhang, Mingqian Zhang, Shuang Cui, et al.
Brain and Behavior (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 20
Immunopathogenic Mechanisms and Novel Immune-Modulated Therapies in Rheumatoid Arthritis
Shyi‐Jou Chen, Gu‐Jiun Lin, Jing-Wun Chen, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1332-1332
Open Access | Times Cited: 53
TNF receptor signalling in autoinflammatory diseases
Heledd Jarosz-Griffiths, Jonathan Holbrook, Samuel Lara‐Reyna, et al.
International Immunology (2019) Vol. 31, Iss. 10, pp. 639-648
Open Access | Times Cited: 48
Blocking only the bad side of IL-6 in inflammation and cancer
Stefan Rose‐John
Cytokine (2021) Vol. 148, pp. 155690-155690
Closed Access | Times Cited: 40
Tumor Necrosis Factor α: Taking a Personalized Road in Cancer Therapy
Adit Ben‐Baruch
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Simplified α2-macroglobulin as a TNF-α inhibitor for inflammation alleviation in osteoarthritis and myocardial infarction therapy
Weiwei Zheng, Tong Zhou, Yuxiang Zhang, et al.
Biomaterials (2023) Vol. 301, pp. 122247-122247
Closed Access | Times Cited: 16
TNFR1 and TNFR2, Which Link NF-κB Activation, Drive Lung Cancer Progression, Cell Dedifferentiation, and Metastasis
Gongping Shi, Yinling Hu
Cancers (2023) Vol. 15, Iss. 17, pp. 4299-4299
Open Access | Times Cited: 13
Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression
Pau Bosch‐Nicolau, María Ubals, Fernando Salvador, et al.
PLoS neglected tropical diseases (2019) Vol. 13, Iss. 8, pp. e0007708-e0007708
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top